Argo Wealth Advisory’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.24M Sell
1,036
-80
-7% -$81.7K 0.69% 42
2026
Q1
$1.03M Sell
1,116
-584
-34% -$592K 0.6% 44
2025
Q4
$1.83M Buy
+1,700
New +$1.63M 1.09% 34

Other funds holding LLY

Argo Wealth Advisory's LLY Position: Q2 2026 in Review

Argo Wealth Advisory reduced its Eli Lilly (LLY) stake by 7.2% in Q2 2026, selling an estimated $81.7K and leaving 1,036 shares worth $1.24M. The position accounts for 0.69% of the portfolio, ranked #42.

Argo Wealth Advisory first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.83M in Q4 2025. 4,594 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Argo Wealth Advisory held 1,036 shares of Eli Lilly worth $1.24M as of Q2 2026.
  • Argo Wealth Advisory sold 80 Eli Lilly shares in Q2 2026, an estimated $81.7K.
  • Eli Lilly made up 0.69% of Argo Wealth Advisory's portfolio in Q2 2026, its #42 holding.
  • Argo Wealth Advisory first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • Argo Wealth Advisory's Eli Lilly position peaked at $1.83M in Q4 2025.
  • 4,594 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Argo Wealth Advisory's 13F filing for Q2 2026, filed 7 Aug 2026.